Document is current
Any future updates will be listed below
-
Authors
Leick, Mark B.
Maus, Marcela V. https://orcid.org/0000-0002-7578-0393
- License Information
-
More Information
Article History
First Online: 15 February 2023
Competing interests
: M.V.M. is an inventor in patents related to adoptive cell therapies, held by the Massachusetts General Hospital (some licensed to Promab) and the University of Pennsylvania (some licensed to Novartis); receives grant and research support from Kite Pharma; has served as a consultant for multiple companies involved in adoptive cell therapies; holds equity in 2SeventyBio, Century Therapeutics, Neximmune, Oncternal and TCR2; and is part of the board of directors for 2Seventy Bio. M.B.L. declares no competing interests.
